Caplin Point Laboratories Ltd
NSE:CAPLIPOINT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Caplin Point Laboratories Ltd
NSE:CAPLIPOINT
|
IN |
|
DW8 Ltd
ASX:DW8
|
AU |
|
F
|
Frontline Ltd
NYSE:FRO
|
BM |
|
F
|
First Republic Bank
F:81R
|
US |
Wall St Price Targets
CAPLIPOINT Price Targets Summary
Caplin Point Laboratories Ltd
According to Wall Street analysts, the average 1-year price target for CAPLIPOINT is 2 555.1 INR with a low forecast of 2 343.2 INR and a high forecast of 2 824.5 INR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CAPLIPOINT's stock price target?
Price Target
2 555.1
INR
According to Wall Street analysts, the average 1-year price target for CAPLIPOINT is 2 555.1 INR with a low forecast of 2 343.2 INR and a high forecast of 2 824.5 INR.
What is the Revenue forecast for Caplin Point Laboratories Ltd?
Projected CAGR
12%
Over the last 8 years, the compound annual growth rate for Revenue has been 22%. The projected CAGR for the next 3 years is 12%.
What is the Gross Profit forecast for Caplin Point Laboratories Ltd?
Projected CAGR
13%
Over the last 8 years, the compound annual growth rate for Gross Profit has been 24%. The projected CAGR for the next 3 years is 13%.
What is the Operating Income forecast for Caplin Point Laboratories Ltd?
Projected CAGR
47%
Over the last 8 years, the compound annual growth rate for Operating Income has been 23%. The projected CAGR for the next 3 years is 47%.
What is the Pre-Tax Income forecast for Caplin Point Laboratories Ltd?
Projected CAGR
13%
Over the last 8 years, the compound annual growth rate for Pre-Tax Income has been 24%. The projected CAGR for the next 3 years is 13%.
What is the Net Income forecast for Caplin Point Laboratories Ltd?
Projected CAGR
13%
Over the last 8 years, the compound annual growth rate for Net Income has been 24%. The projected CAGR for the next 3 years is 13%.
